Emanuele Crupi Antiangiogenic Therapy

Emanuele Crupi: Antiangiogenic Therapy Combined with Immune Checkpoint Blockade in Urothelial Cancer

Emanuele Crupi, Fellow in Medical Oncology at San Raffaele University-Hospital, shared a post on LinkedIn about a recent paper by him and colleagues published in Bladder Cancer:

“Out now in Bladder Cancer.

Antiangiogenic Therapy Combined with Immune Checkpoint Blockade in Urothelial Cancer: Systematic Review and Meta-Analysis.

Spoiler candy:

Objective Response Rate

  • ICI-naïve (ICI-N): 34%
  • ICI-exposed (ICI-E): 16%

Looking forward to feedback and discussions from the community!”

“Antiangiogenic therapy combined with immune checkpoint blockade in urothelial cancer: Systematic review and meta-analysis”

Authors: Mohammad Moussa, Iuliia Kovalenko, Emanuele Crupi, Ekaterina Proskuriakova, Yimin Geng, Giuseppe Fallara, Raed Benkhadra, Daniele Raggi, Matthew Campbell, Pavlos Msaouel, Omar Alhalabi.

Emanuele Crupi: Antiangiogenic Therapy Combined with Immune Checkpoint Blockade in Urothelial Cancer

More posts featuring Emanuele Crupi.

antiangiogenic therapy bladder cancer cancer Daniele Raggi Ekaterina Proskuriakova Emanuele Crupi Giuseppe Fallara Iuliia Kovalenko Matthew Campbell Mohammad Moussa Omar Alhalabi OncoDaily Oncology Pavlos Msaouel Raed Benkhadra urothelial cancer Yimin Geng